Navigation Links
AIT Laboratories Expands Pharma Services

Names Industry Veteran as Executive Director

INDIANAPOLIS, Sept. 22 /PRNewswire/ -- AIT Laboratories, a leading forensics, pain management, clinical, and pharmaceutical testing facility, is announcing the expansion of its pharmaceutical services and has chosen an industry veteran to lead the division. AIT has named Ronald Shoup, former co-founder and chief scientific officer of West Lafayette-based Bioanalytical Systems, Inc. (Nasdaq: BASI), as its executive director of Pharma Services. "Ron brings 30 years of leadership, entrepreneurship, and scientific expertise to AIT as we look to expand our facility to meet the growing needs of the Pharma industry," said AIT President and CEO Michael A. Evans, Ph.D.

AIT supports clinical trials through its current drug analysis services and expects to offer regulated bioanalytical services for preclinical development in the future. Almost 20 years of experience in sample management enables AIT to offer the highest quality of organization for the collection, distribution, maintenance, and reconciliation of samples from clinical studies. As a premier leader in the application of mass spectrometry for biological samples, AIT routinely develops, validates, and performs mass spectrometry analysis in support of new drug development.

"My experience in analytical chemistry, regulatory audits, and the Pharma/biotech industry has given me challenging opportunities to solve scientific problems in drug development," said Shoup. "I know that my skills can help AIT to further enhance its success and reputation in the industry."

As pharmaceutical companies are going more towards their core business of making drugs, AIT is filling a need of providing superior bioanalytical testing in support of clinical trials. "Pharmaceutical companies are demanding high-quality, bioanalytical testing, analyses of biological samples, regulatory compliance, a commitment to quality assurance, robust methods development, and state-of-the-art technology," said AIT Chief Scientific Officer Andrea Terrell, Ph.D. "AIT provides all of these services to our clients."

AIT is a company that boasts an impressive collection of more than 100 bioanalytical assay methods, which identify over 300 drugs using some of the most advanced instrumentation in the industry. Through the innovations of its dedicated staff and scientists using multiple mass spectrometers and tandem mass spectrometer detectors coupled with GC, HPLC, and UPLC chromatography systems, AIT has seen phenomenal growth in its current markets over the past several years and is now using that success to further pursue the pharmaceutical industry. "I loved the growth story at AIT, and it was obvious to me that the company's culture and flexibility has allowed it to respond to its fast-growing markets," said Shoup.

About AIT Laboratories:

AIT Laboratories, headquartered in Indianapolis, Ind., is an independent reference laboratory that is a premiere testing and research institution recognized nationwide for superior customer service and quality in testing. In 2008, AIT was named one of the "Best Places to Work in Indiana" by the Indiana Chamber of Commerce. In 2007 and 2008, AIT was recognized by Inc. magazine as one of the top 5,000 fastest-growing, private companies in the nation. Learn more about AIT Laboratories at .

Contact: Raquel Bahamonde

Executive Director of Corporate Communications, AIT Laboratories

Phone: (317) 243-3894, ext. 476

Cell: (317) 308-0064

E-mail: Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Andrea Terrell Michael Evans

SOURCE AIT Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Appoints Singapore Laboratories Managing Director
2. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
3. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Stiefel Laboratories Appoints Two New Members to Board of Directors
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
7. ARUP Laboratories Releases ARUP Consult(R) 2.0
8. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
9. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
10. Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Post Your Comments:
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):